Estimation of absolute renal uptake with technetium-99m dimercaptosuccinic acid
direct comparison with the radioactivity of nephrectomy specimens
Keywords:
99mTc-DMSA, Scintigraphy, Nephrectomy, Kidney cortex, Nuclear medicineAbstract
CONTEXT AND OBJECTIVE: Studies using radionuclides are the most appropriate method for estimating renal function. Dimercaptosuccinic acid chelate labeled with technetium-99m (99mTcDMSA) is the radiopharmaceutical of choice for high-resolution imaging of the renal cortex and estimation of the functional renal mass. The aim of this study was to evaluate a simplifi ed method for determining the absolute renal uptake (ARU) of 99mTc-DMSA prior to nephrectomy, using the radioactivity counts of nephrectomy specimens as the gold standard. DESIGN AND SETTING: Prospective study at the Division of Nuclear Medicine, Department of Radiology, Universidade Estadual de Campinas. METHODS: Seventeen patients (12 females; range 22-82 years old; mean age 50.8 years old) underwent nephrectomy for various reasons. Renal scintigraphy was performed three to four hours after intravenous administration of a mean dose of 188.7 MBq (5.1 mCi) of 99mTc-DMSA, which was done six to 24 hours before surgery. The in vivo renal uptake of 99mTc-DMSA was determined using the radioactivity of the syringe before the injection (measured using a dose calibrator) and the images of the syringe and kidneys, obtained from a scintillation camera. After surgery, the reference value for renal uptake of 99mTc-DMSA was determined by measuring the radioactivity of the nephrectomy specimen using the same dose calibrator. RESULTS: The ARU measurements were very similar to those obtained using the reference method, as determined by linear regression (r-squared = 0.96). CONCLUSION: ARU estimation using the proposed method before nephrectomy seems to be accurate and feasible for routine use.
Downloads
References
Lin TH, Khentigan A, Winchell HS. A 99mTc-chelate sub- stitute for organoradiomercurial renal agents. J Nucl Med. 1974;15(1):34-5.
Müller-Suur R, Magnusson G, Bois-Svensson I, Jansson B. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample. Eur J Nucl Med. 1991;18(1):28-31.
Taylor A. Radiopharmaceuticals for the measurement of ‘func- tional renal mass’. In: Blaufox MD, editor. Evaluation of renal function and disease with radionuclides: the upper urinary tract. Basel: Karger; 1989. p. 60-83.
Daly MJ, Jones W, Rudd TG, Tremann J. Differential renal func- tion using technetium-99m dimercaptosuccinic acid (DMSA): in vitro correlation. J Nucl Med. 1979;20(1):63-6.
Higashihara E, Tokuda H, Kishi H, et al. Technetium- 99m dimercaptosuccinic acid uptake in long-term cath- eterized kidney. Comparison with renal function. Urology. 1988;31(4):327-31.
Bingham JB, Maisey MN. An evaluation of the use of 99Tcm- dimercaptosuccinic acid (DMSA) as a static renal imaging agent. Br J Radiol. 1978;51(608):599-607.
Taylor A Jr. Quantitation of renal function with static imaging agents. Semin Nucl Med. 1982;12(4):330-44.
Kawamura J, Hosokawa S, Yoshida O. Renal function stud- ies using 99mTc-dimercaptosuccinic acid. Clin Nucl Med. 1979;4(1):39-46.
Kawamura J, Hosokawa S, Yoshida O, Fujita T, Ishii Y, Torizuka
K. Validity of 99mTc dimercaptosuccinic acid renal uptake for an assessment for individual kidney function. J Urol. 1978;119(3):305-9.
Tonnensen KH, Munch O, Hald T, et al. Influence on the renogram of variation skin to kidney distance and the clinical importance hereof. In: Zum Winkel K, Blaufox MD, Funck- Brentano JL, editors. Radionuclides in Nephrology, Proceedings of the Third International Symposium on Radionuclides in Nephrology. Berlin: Thieme; 1974. p. 79-86.
Gates GF. Split renal function testing using Tc-99m DTPA. A rapid technique for determining differential glomerular filtra- tion. Clin Nucl Med. 1983;8(9):400-7.
Groshar D, Moskovitz B, Gorenberg M, et al. Quantitative SPECT of technetium-99m-DMSA uptake in the kidneys of normal children and in kidneys with vesicoureteral reflux: detection of unilateral kidney disease. J Nucl Med. 1994;35(3):445-9.
Mullerad M, Kastin A, Issaq E, Moskovitz B, Groshar D, Nativ
O. The value of quantitative 99m technetium dimercaptosuc- cinic acid renal scintigraphy for predicting postoperative renal insufficiency in patients undergoing nephrectomy. J Urol. 2003;169(1):24-7.
Kawamura J, Itoh H, Okada Y, et al. Preoperative and postopera- tive cortical function of the kidney with staghorn calculi assessed by 99mtechnetium-dimercaptosuccinic acid renal scintigraphy. J Urol. 1983;130(3):430-3.
Goldraich NP, Goldraich IH, Anselmi OE, Ramos OL. Reflux nephropathy: the clinical picture in South Brazilian children. Contrib Nephrol. 1984;39:52-67.
Raynaud C. A technique for the quantitative measurement of the function of each kidney. Semin Nucl Med. 1974;4(1):51-60.
Morris SC, Chittenden SJ, Rivens I, Heary TA, Vanstone C, Meller ST. Absolute 99Tcm-DMSA renal uptake in children: a study of 321 kidneys. Nucl Med Commun. 1995; 16(7):566-71.
Iosilevsky G, Israel O, Frenkel A, et al. A practical SPECT technique for quantitation of drug delivery to human tu- mors and organ absorbed radiation dose. Semin Nucl Med. 1989;19(1):33-46.
Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol. 1982;138(3):565-70.
Chachati A, Meyers A, Godon JP, Rigo P. Rapid method for the measurement of differential renal function: validation. J Nucl Med. 1987;28(5):829-36.
Taylor A, Lewis C, Giacometti A, Hall EC, Barefield KP. Improved formulas for the estimation of renal depth in adults. J Nucl Med. 1993;34(10):1766-9.
Gordon I. Indications for 99mtechnetium dimercapto-succinic acid scan in children. J Urol. 1987;137(3):464-7.
Moorin R. 99mTc-DMSA absolute uptake: normal pediatric values at 2-4 hours. J Nucl Med Technol. 2001;29(1):22-9.
Flower MA, Meller ST, Chittenden SJ, Fielding SL, Evans K, Gor- don I. Absolute 99Tcm-DMSA renal uptake in children: optimum time to scan. Nucl Med Commun. 1995;16(7):572-4.
